Stockreport

Kazia Therapeutics: Diverse Cancer Pipeline Still Needs A Major Catalyst [Seeking Alpha]

Kazia Therapeutics Limited - American Depositary Shares  (KZIA) 
US:NASDAQ Investor Relations: kaziatherapeutics.com
PDF Paxalisib is also being explored across CNS tumors and TNBC, giving Kazia broad oncology optionality but limited near-term validation. NDL2 and SETDB1 add differentia [Read more]